Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)

被引：17

作者：

Hadziyannis, S

Tassopoulos, N

Chang, TT

Heathcote, J

Kitis, G

Rizzetto, M

Marcellin, P

Lim, SG

Chen, SS

Arterburn, S

Ma, J

Xiong, S

Wollman, M

James, C

Currie, G

Brosgart, CL

机构：

[1] Henry Dunant Hosp, Athens, M5T 2S8, Greece

[2] Western Attica Hosp, Athens, Greece

[3] Natl Cheng Kung Hosp, Taipei, Taiwan

[4] Toronto Western Hosp, Toronto, ON, Canada

[5] Georgios Papanikolaou Hosp, GR-54636 Thessaloniki, Greece

[6] Azienda Osped San Giovanni Battista, Turin, 94404, Italy

[7] Hop Beaujon, Clichy, France

[8] Natl Univ Singapore, Singapore 117548, Chane, Singapore

[9] Gilead Sci Inc, Foster City, CA USA

来源：

关键词：

D O I：

10.1016/S0168-8278(04)90046-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：17 / 17

页数：1